In addition, we found the up-regulation of genes as the chemokine CXCL10, involved in immune and inflammatory processes and that posses anti-angiogenic activity, which are associated with increased immune infiltration and improved survival in patients with solid malignancies including breast cancer [36, 37]. Here, CXCL10 is linked to breast carcinoma.